Evaluation of a Proactive Clinical Management and Early Diagnosis of Arrhythmias in Patients With Heart Failure and Non Severely Reduced Left Ventricular Function Through a Telemonitoring System

NCT05974306 — Not applicable, Not yet recruiting, 331 participants, Leonardo Calò, MD

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Evaluation of a Proactive Clinical Management and Early Diagnosis of Arrhythmias in Patients With Heart Failure and Non Severely Reduced Left Ventricular Function Through a Telemonitoring System: a Prospective Randomized Clinical Trial (VASCO)

RegistryNCT05974306, acronym VASCO
StatusNot yet recruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, diagnostic
Enrollment331 (Estimated)
SponsorLeonardo Calò, MD (Other)
ConditionsHeart Failure, Arrhythmias, Cardiac
Interventionsimplantable loop recorder (Device)
Datesstart 2023-09-01 (estimated), primary completion 2024-06-01 (estimated), completion 2027-06-01 (estimated), first posted 2023-08-03, last updated 2023-08-03

Related Papers Related Patents Related Grants Related Experts
All trials for Heart Failure All trials for Arrhythmias, Cardiac All trials of implantable loop recorder

-Summary

Vasco trial is a no profit, multicenter, international, prospective, randomized study designed to evaluate the clinical benefits of a remote monitoring management based on ILR vs standard practice in patients with high risk of cardiac arrhythmias, heart failure and left ventricle ejection fraction (LVEF)> 40% .The study will enroll about 331 patients (221 in the ILR group and 110 in the in-hospital follow-up group).

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
ILR groupExperimentalDevice: implantable loop recorderpatients implanted with an implantable loop recorder to be monitored remotely.
in-hospital fup groupNo interventionPatients that will be followed with in-hospital visits.
  • implantable loop recorder (Device): Implantation of an implantable loop recorder

+Outcome measures

Primary outcomes

  • Evaluate the benefits of a remote monitoring management based on ILR vs standard practice in patients with high risk of cardiac arrhythmias, heart failure and LVEF> 40% in the detection of significant clinical events. [2 years]: Detection rate of arrhythmias that require treatment (medical or interventional)

+Eligibility

Sex: All, ages: 18 Years to 100 Years

Inclusion Criteria:

* Patients with heart failure, LVEF> 40% who report episodes of palpitations.
* Over 18 years of age
* Ability to provide informed consent for registry participation and be willing and able to comply with the protocol described evaluations

Exclusion Criteria:

* Subject who is, or is expected to be unavailable for follow-up
* Pregnancy
* Medical contraindications for ILR implantation
* Patients with PMK / ICD or with Indication for ICD / PMK implantation
* Cardiovascular events / myocardial revascularization in the previous three months
* Patients already on oral anticoagulant treatment
* Patients who do not want to use the telemonitoring system
* Presence of other recognized indications to ILR (Unexplained syncope, cryptogenic stroke/TIA, Transient loss of consciousness and recurrent falls)